HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Clinical trial NCT05586074 · RECRUITING

Trial details

NCT number: NCT05586074
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Acute Myeloid (AML)

Start date: 2023-03-03
Primary completion: 2027-11-30
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.